Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate to Severe Atopic Eczema”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03556592
What this trial is testing

Drug-drug Interaction Trial With Tralokinumab in Moderate to Severe Atopic Dermatitis - ECZTRA 4

Who this might be right for
Atopic Dermatitis
LEO Pharma 40
Testing effectiveness (Phase 2)Study completedNCT01785602
What this trial is testing

Efficacy and Safety Study of QAW039 in the Treatment of Patients With Moderate to Severe Atopic Dermatitis.

Who this might be right for
Atopic Dermatitis
Novartis Pharmaceuticals 103
Testing effectiveness (Phase 2)Study completedNCT04922021
What this trial is testing

An Evaluation of LEO 138559 in Adults With Moderate to Severe Atopic Dermatitis.

Who this might be right for
Atopic Dermatitis
LEO Pharma 58
Testing effectiveness (Phase 2)Study completedNCT06012812
What this trial is testing

Extend Efficacy and Safety of SHR-1819 Injection in Adult Patients With Moderate to Severe Atopic Dermatitis

Who this might be right for
Moderate to Severe Atopic Dermatitis
Shanghai Hengrui Pharmaceutical Co., Ltd. 79
Testing effectiveness (Phase 2)Study completedNCT02576938
What this trial is testing

Baricitinib (LY3009104) in Participants With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Eli Lilly and Company 124
Post-approval studies (Phase 4)Ended earlyNCT03257215
What this trial is testing

Can Vitamin D Treatment Help Treat Moderate to Severe Atopic Dermatitis in Young Children? the D-Vex Pilot Study

Who this might be right for
Atopic Dermatitis
Murdoch Childrens Research Institute 13
Testing effectiveness (Phase 2)Study completedNCT02002208
What this trial is testing

Effect of OC000459 on Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Atopix Therapeutics, Ltd. 142
Testing effectiveness (Phase 2)Study completedNCT02347176
What this trial is testing

Phase 2 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
MedImmune LLC 204
Post-approval studies (Phase 4)Study completedNCT00832585
What this trial is testing

Study to Evaluate the Safety and Efficacy of Alefacept (Amevive) in Subjects With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Rush University Medical Center 5
Large-scale testing (Phase 3)Study completedNCT05633355
What this trial is testing

Assess the Safety, Tolerability, and Efficacy of Rocatinlimab in Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)

Who this might be right for
Atopic Dermatitis
Amgen 187
Not applicableNot Yet RecruitingNCT07741838
What this trial is testing

Effectiveness of Upadacitinib and Biologics for the Achievement of Minimal Disease Activity in Adults With Moderate-to-Severe Atopic Dermatitis (RAMpUp)

Who this might be right for
Atopic Dermatitis
AbbVie 900
Post-approval studies (Phase 4)UnknownNCT03461302
What this trial is testing

Efficacy of Topical Coal Tar in Children With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Radboud University Medical Center 80
Large-scale testing (Phase 3)Not Yet RecruitingNCT07754786
What this trial is testing

Evaluate the Equivalence of IBI3027 and Dupilumab Injection in Participants With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Innovent Biologics (Suzhou) Co. Ltd. 520
Testing effectiveness (Phase 2)Active Not RecruitingNCT07321951
What this trial is testing

SHR-1819 in Patients With Moderate-to-severe Atopic Dermatitis

Who this might be right for
Moderate-to-severe Atopic Dermatitis
Guangdong Hengrui Pharmaceutical Co., Ltd 201
Testing effectiveness (Phase 2)Ended earlyNCT05935085
What this trial is testing

This Study Will Evaluate the Safety, Tolerability, and Efficacy of ANB032 in Subjects with Moderate to Severe Atopic Dermatitis (AD).

Who this might be right for
Atopic Dermatitis Eczema
AnaptysBio, Inc. 201
Not applicableLooking for participantsNCT06899204
What this trial is testing

Real World Efficiency of Abrocitinib Treatment at Patients With Moderate to Severe Atopic Dermatitis Who Had Inadequate Response to Previous Biologic Therapies.

Who this might be right for
Atopic DermatitisAtopic Dermatitis, UnspecifiedDermatitis, Atopic
Pfizer 150
Not applicableLooking for participantsNCT03057860
What this trial is testing

TREATgermany: German National Clinical Registry for Patients With Moderate-to-severe Atopic Dermatitis

Who this might be right for
Moderate-to-severe Atopic Dermatitis
Technische Universität Dresden 2,800
Testing effectiveness (Phase 2)Ended earlyNCT03245385
What this trial is testing

Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spray in Patients With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Sun Pharmaceutical Industries Limited 20
Testing effectiveness (Phase 2)Study completedNCT03059693
What this trial is testing

Efficacy and Tolerability of HAT1 in Patients With Moderate to Severe Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
Haus Bioceuticals 48
Large-scale testing (Phase 3)Study completedNCT03435081
What this trial is testing

Baricitinib (LY3009104) in Adult Participants With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Eli Lilly and Company 440
Next Page